Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19333200rdf:typepubmed:Citationlld:pubmed
pubmed-article:19333200lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:19333200lifeskim:mentionsumls-concept:C0014544lld:lifeskim
pubmed-article:19333200lifeskim:mentionsumls-concept:C0003243lld:lifeskim
pubmed-article:19333200lifeskim:mentionsumls-concept:C0033105lld:lifeskim
pubmed-article:19333200pubmed:issue4lld:pubmed
pubmed-article:19333200pubmed:dateCreated2009-3-31lld:pubmed
pubmed-article:19333200pubmed:abstractTextAntiphospholipid syndrome (APS) is an autoimmune disorder characterized by recurrent venous thrombosis or arterial occlusive events and fetal losses associated with elevated levels of antiphospholipid antibodies (aPLs).lld:pubmed
pubmed-article:19333200pubmed:languageenglld:pubmed
pubmed-article:19333200pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19333200pubmed:citationSubsetIMlld:pubmed
pubmed-article:19333200pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19333200pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19333200pubmed:statusMEDLINElld:pubmed
pubmed-article:19333200pubmed:monthAprlld:pubmed
pubmed-article:19333200pubmed:issn1643-3750lld:pubmed
pubmed-article:19333200pubmed:authorpubmed-author:DankóKatalinKlld:pubmed
pubmed-article:19333200pubmed:authorpubmed-author:NagyEszterElld:pubmed
pubmed-article:19333200pubmed:authorpubmed-author:GergelyPéterPlld:pubmed
pubmed-article:19333200pubmed:authorpubmed-author:PonyiAndreaAlld:pubmed
pubmed-article:19333200pubmed:authorpubmed-author:ConstantinTam...lld:pubmed
pubmed-article:19333200pubmed:authorpubmed-author:FeketeGyörgyGlld:pubmed
pubmed-article:19333200pubmed:authorpubmed-author:MüllerJuditJlld:pubmed
pubmed-article:19333200pubmed:authorpubmed-author:GaramiMiklósMlld:pubmed
pubmed-article:19333200pubmed:authorpubmed-author:SallaiKriszti...lld:pubmed
pubmed-article:19333200pubmed:authorpubmed-author:KálmáncheyRoz...lld:pubmed
pubmed-article:19333200pubmed:authorpubmed-author:SzabóLénaLlld:pubmed
pubmed-article:19333200pubmed:authorpubmed-author:KálovicsTamás...lld:pubmed
pubmed-article:19333200pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19333200pubmed:volume15lld:pubmed
pubmed-article:19333200pubmed:ownerNLMlld:pubmed
pubmed-article:19333200pubmed:authorsCompleteYlld:pubmed
pubmed-article:19333200pubmed:paginationCR164-9lld:pubmed
pubmed-article:19333200pubmed:meshHeadingpubmed-meshheading:19333200...lld:pubmed
pubmed-article:19333200pubmed:meshHeadingpubmed-meshheading:19333200...lld:pubmed
pubmed-article:19333200pubmed:meshHeadingpubmed-meshheading:19333200...lld:pubmed
pubmed-article:19333200pubmed:meshHeadingpubmed-meshheading:19333200...lld:pubmed
pubmed-article:19333200pubmed:meshHeadingpubmed-meshheading:19333200...lld:pubmed
pubmed-article:19333200pubmed:meshHeadingpubmed-meshheading:19333200...lld:pubmed
pubmed-article:19333200pubmed:meshHeadingpubmed-meshheading:19333200...lld:pubmed
pubmed-article:19333200pubmed:meshHeadingpubmed-meshheading:19333200...lld:pubmed
pubmed-article:19333200pubmed:meshHeadingpubmed-meshheading:19333200...lld:pubmed
pubmed-article:19333200pubmed:meshHeadingpubmed-meshheading:19333200...lld:pubmed
pubmed-article:19333200pubmed:meshHeadingpubmed-meshheading:19333200...lld:pubmed
pubmed-article:19333200pubmed:year2009lld:pubmed
pubmed-article:19333200pubmed:articleTitlePrevalence of antiphospholipid and antinuclear antibodies in children with epilepsy.lld:pubmed
pubmed-article:19333200pubmed:affiliation2nd Department of Pediatrics, Semmelweis University, Faculty of Medicine, Budapest, Hungary. ctamas@gyer2.sote.hulld:pubmed
pubmed-article:19333200pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19333200pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed